http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2194135-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40118c337b4346ca992701db124ce708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_071ec59bb09b2d4939e261f44c36eebd |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 1995-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89450b00352f954914980aef3b096ebf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_248a84f34869c8580a3c34df60b0973a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cf5ca4a8505f5ea8a2a385446b06745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6cc02d76d4cba625c029c9edb3118f2 |
| publicationDate | 2006-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2194135-C |
| titleOfInvention | Recombinant mono and poly antigens to detect cytomegalovirus-specific igm in human sera by enzyme immunoassay |
| abstract | A mixture of recombinant mono- and poly-epitope proteic materials able to fully replace the viral antigens when used in an enzyme immunoassay (EIA) is disclosed; the mixture includes a poly-epitope fusion protein having a first region formed by an amino acid sequence (H10) corresponding to that of the last 233 amino acids of the COOH terminus of the vital protein p52 or to a part thereof, a second region formed by an amino acid sequence (F3) corresponding to that of the la st 43 amino acids of the COOH terminus of viral protein pp150 or to a part thereof, and a third region formed by an amino acid sequence (AlC2) corresponding to that taken from as 595 to aa 614, proceeding in direction 5'.fwdarw.3', of the same viral protein pp150; and, in combination, a second fusion protein including a sequence of amino acids corresponding to that taken, proceeding in direction 5'.fwdarw.3' from as 297 to aa 510 of the viral major matrix protein pp65 encoded by the viral gene UL83 and a third fusion protein including a sequen ce of amino acids corresponding to that taken, proceeding in direction 5'.fwdarw.3', from as 117 to as 373 of the vital assembly protein pp38 encoded by the viral gene UL80a. These three fusion proteins may be used combined together for the preparation of an ELISA test kit for detection of Cytomegalovirus-specific Igm in human sera. |
| priorityDate | 1994-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 485.